ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Mississippi » Nephrology

Top Nephrology Prescribers in Mississippi

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MURPHY MARTIN MD

Nephrology

9,369

$650K

496
336 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 27%

$69
Average prescription price

Avg: $106

AMITA PATEL M.D.

Nephrology

9,113

$937K

349
202 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

11%
patients receiving schedule three controlled substances

Avg: 12%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 27%

$103
Average prescription price

Avg: $106

BRAXTER IRBY MD

Nephrology

8,101

$707K

428
254 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

14%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 27%

$87
Average prescription price

Avg: $106

JOHN LEE MD

Nephrology

8,092

$1.11M

652
314 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

12%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 27%

$137
Average prescription price

Avg: $106

THOMAS WOOLDRIDGE MD

Nephrology

7,988

$1.12M

622
306 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

14%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 27%

$140
Average prescription price

Avg: $106

KENNETH KOKKO M.D.

Nephrology

6,688

$280K

324
49 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 27%

$42
Average prescription price

Avg: $106

JONATHAN MASSEY MD

Nephrology

5,859

$469K

446
250 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

10%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 27%

$80
Average prescription price

Avg: $106

JON THORNTON MD

Nephrology

5,558

$467K

598
293 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

16%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 27%

$84
Average prescription price

Avg: $106

HARVEY GERSH MD

Nephrology

5,509

$573K

540
256 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 27%

$104
Average prescription price

Avg: $106

MORRIS HAMILTON MD

Nephrology

5,105

$483K

295
154 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

18%
patients receiving schedule three controlled substances

Avg: 12%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 27%

$95
Average prescription price

Avg: $106

JOSEPH O'GORMAN D.O.

Nephrology

5,083

$325K

289
158 are 65+

7%
patients receiving schedule two controlled substances

Avg: 0%

20%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 27%

$64
Average prescription price

Avg: $106

THOMAS DUNN D.O.

Nephrology

4,933

$454K

244
89 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

41%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 27%

$92
Average prescription price

Avg: $106

CHRISTOPHER LEBRUN M.D.

Nephrology

4,915

$624K

313
148 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

23%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 27%

$127
Average prescription price

Avg: $106

DOUGLAS LANIER M.D.

Nephrology

4,451

$395K

266
159 are 65+

5%
patients receiving schedule two controlled substances

Avg: 0%

20%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 27%

$89
Average prescription price

Avg: $106

DAPHNE BILBREW MD

Nephrology

4,332

$314K

300
160 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

15%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 27%

$73
Average prescription price

Avg: $106

PAUL DYKES MD

Nephrology

4,093

$546K

359
186 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

16%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 27%

$133
Average prescription price

Avg: $106

AMERY CREIGHTON M.D.

Nephrology

4,045

$280K

272
146 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

17%
patients receiving schedule three controlled substances

Avg: 12%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 27%

$69
Average prescription price

Avg: $106

JOHN O'BRIEN M.D.

Nephrology

3,710

$374K

230
113 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

32%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 27%

$101
Average prescription price

Avg: $106

ANGELA RILEY MD

Nephrology

3,350

$297K

198
116 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 27%

$89
Average prescription price

Avg: $106

KENNETH KELLUM MD

Nephrology

3,335

$298K

426
220 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

15%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 27%

$89
Average prescription price

Avg: $106

MARK KLEIN MD

Nephrology

3,285

$248K

212
128 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

10%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 27%

$75
Average prescription price

Avg: $106

RICHARD MILLER M.D.

Nephrology

3,283

$319K

343
182 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

11%
patients receiving schedule three controlled substances

Avg: 12%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 27%

$97
Average prescription price

Avg: $106

NOUHAD KRONFOL M.D.

Nephrology

3,248

$390K

250
114 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

17%
patients receiving schedule three controlled substances

Avg: 12%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 27%

$120
Average prescription price

Avg: $106

A BOONE M.D.

Nephrology

3,214

$231K

277
132 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 27%

$72
Average prescription price

Avg: $106

TRACY PITTMAN M.D.

Nephrology

3,188

$590K

154
77 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

13%
patients receiving schedule three controlled substances

Avg: 12%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 27%

$185
Average prescription price

Avg: $106

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank